The agency has approved a four-dose version of the drug, called Mounjaro KwikPen, which provides a month’s course of GLP-1 and GIP agonist tirzepatide. Great Britain will be the first major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback